https://prabadinews.com/
  • October 9, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use

FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use

The approval builds upon concizumab’s previous December 2024 clearance and allows for treatment in patients with hemophilia A or B, both with or without inhibitors.

administrator

Related Articles